Recent data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show a large increase of +57% in Acinetobacter species bloodstream infections in the European Union and European Economic Area in the first years of the COVID-19 pandemic (2020-2021) compared with 2018-2019. Most were resistant to carbapenems, from intensive care units, and in countries with ≥ 50% carbapenem resistance in Acinetobacter spp. in 2018-2019. This highlights the requirement for reinforced Acinetobacter preparedness and infection prevention and control in Europe.
All Keywords
【저자키워드】 COVID-19, pandemic, Acinetobacter, Bacteraemia, EU/EEA,
【저자키워드】 COVID-19, pandemic, Acinetobacter, Bacteraemia, EU/EEA,